Who owns the TAUROKINASE trademark?

The TAUROKINASE trademark is owned by TauroPharm GmbH.

What class is the TAUROKINASE trademark registered in?

The TAUROKINASE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for TAUROKINASE?

The USPTO serial number for TAUROKINASE is 79311887.

What is the registration number for TAUROKINASE?

TAUROKINASE is registered under USPTO registration number 6776841.

TAUROKINASE - Owned by TauroPharm GmbH - (Class 005)

What to file next

Section 8 declaration of continued use

When: Due between the fifth and sixth anniversary of registration.
Extensions and grace: A six-month grace period follows, with an added per-class fee.
If it is missed: A missed Section 8 cancels the registration, and there is no revival route for it.

How the Section 8 deadline works

General information about USPTO practice, not legal advice. The register is the authority, and a filing that has not yet posted can change what is owed.

Full Goods & Services

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Status History

26 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 07, 2022

Code FINV

FINAL DISPOSITION PROCESSED

Oct 15, 2022

Code FIMP

FINAL DISPOSITION NOTICE SENT TO IB

Oct 15, 2022

Code FICS

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 05, 2022

Code FICR

REGISTERED-PRINCIPAL REGISTER

Jul 05, 2022

Code R.PR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 05, 2022

Code NRCC

NOTIFICATION PROCESSED BY IB

May 03, 2022

Code GPNX

PUBLISHED FOR OPPOSITION

Apr 19, 2022

Code PUBO

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 19, 2022

Code NPUB

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 13, 2022

Code OP2R

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 13, 2022

Code OPNS

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 30, 2022

Code NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2022

Code CNSA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 15, 2022

Code CRFA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 15, 2022

Code TEME

ASSIGNED TO LIE

Mar 14, 2022

Code ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 11, 2022

Code TROA

REFUSAL PROCESSED BY IB

Nov 15, 2021

Code RFNT

REFUSAL PROCESSED BY MPU

Oct 25, 2021

Code RFRR

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 25, 2021

Code RFCS

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 06, 2021

Code RFCR

NON-FINAL ACTION WRITTEN

Oct 05, 2021

Code CNRT

ASSIGNED TO EXAMINER

Sep 28, 2021

Code DOCK

APPLICATION FILING RECEIPT MAILED

Jun 05, 2021

Code MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 01, 2021

Code NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 27, 2021

Code REPR

Other Marks by TauroPharm GmbH

Additional USPTO filings from the same owner.

TAU

TAUROLOCK

87338630

TauroPharm GmbH

ABANDONED

TAU

TAUROLOCK

79079356

TauroPharm GmbH

ABANDONED

Other Marks by MONTRA YAZDANI

Additional USPTO filings handled by the same attorney of record.

DUN

DUNMORE CORPORATION

78473445

REGISTERED

PLA

PLAZA RECORDS

99781985

REGISTERED

PLA

PLAZA RECORDS

99781990

REGISTERED

MOD

MODUSLINK

78469055

REGISTERED

TAUROKINASE

What to file next

Full Goods & Services

Filing Basis & Declarations

Other Marks by TauroPharm GmbH

Other Marks by MONTRA YAZDANI

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions